Today, volatile gas anesthetics are commonly used in medicine for various procedures. While they are effective and safe for most adults, multiple or long exposures of anesthesia to young children and infants is thought to carry the risks of neurodevelopmental defects due to the well-established neurotoxic effects of anesthetics on the developing nervous system, referred to as anesthesia induced neurotoxicity (AIN). If the mechanisms of anesthesia and AIN can be studied and better understood, strategies to prevent defects associated with AIN can potentially be developed. At the Seattle Children’s Research Institute, I am assisting as an undergraduate researcher in a project to better understand AIN. My project specifically involves using C. elegans, a laboratory invertebrate species, to study the effects of anesthesia on neurotoxicity in specific developmental stages, including programmed cell death (apoptosis). The short life span and rapid reproductive cycle of these nematodes make them great models for this study because isoflurane exposure has been observed to induce AIN in these organisms. I am working to research the specific developmental stages of C. elegans that isoflurane affects the most. In lab, I am culturing worms to known stages of development, using green flourescent protein (GFP) reporter strains as markers to study apoptosis (specifically in the apoptoic proteins ced-3, ced-1, and ced-10), and exposing worms to isoflurane during these stages. Using PCR, western-blotting, and imaging techniques, I am analyzing the proteins, neurons, and developmental stage(s) impacted by AIN. This should provide new insight into the proteins and specific neurons that anesthesia induced neurotoxicity targets. By carefully analyzing the mechanisms of AIN, I hope to gain knowledge about how it can damage normal neuronal function in C. Elegans that can eventually be applied to humans.